The DOI matches its Crossref record; 82 of the 82 references it cites were found in a registry or an index.
Mechanism of NLRP3 inflammasome activation
Open accessAbstract
Inflammasomes continue to generate interest in an increasing number of disciplines owing to their unique ability to integrate a myriad of signals from pathogen- and damage-associated molecular patterns into a proinflammatory response. This potent caspase-1-dependent process is capable of activating the innate immune system, initiating pyroptosis (an inflammatory form of programmed cell death), and shaping adaptive immunity. The NLRP3 inflammasome is the most thoroughly studied of the inflammasome complexes that have been described thus far, perhaps owing to its disparate assortment of agonists. This review highlights our current understanding of the mechanisms of both priming and activation of the NLRP3 inflammasome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“this has been shown to elicit activation of the NLRP3 inflammasome in LPS-stimulated macrophages, which causes secretion of IL-18 (but also of the pro-inflammatory cytokine IL-1β) and may thus promote maintenance and function of the epithelial barrier (Mariathasan et al., 2006; Sutterwala et al., 2014; 2006; Yaron et al., 2015).”
From Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System (2017) · cites this paper as Sutterwala et al., 2014
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Martinon, F., Burns, K., & Tschopp, J. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00599-3 · Cited by 6,066
A role for mitochondria in nlrp3 inflammasome activation
Zhou, R., Yazdi, A. S., Menu, P., & Tschopp, J. (2011) · Nature · doi:10.1038/nature09663 · Cited by 5,602
Immunological and inflammatory functions of the interleukin-1 family
Dinarello, C. A. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132612 · Cited by 3,466
Bauernfeind, F. G., Horvath, G. L., Stutz, A., Alnemri, E. S., MacDonald, K. L., Speert, D. P., Fernandes‐Alnemri, T., Wu, J., Monks, B. G., Fitzgerald, K. A., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901363 · Cited by 3,087
Nakahira, K., Haspel, J. A., Rathinam, V. A. K., Lee, S.-J., Dolinay, T., Lam, H. C., Englert, J. A., Rabinovitch, M., Cernadas, M., Kim, H. P., et al. (2011) · Nature Immunology · doi:10.1038/ni.1980 · Cited by 3,049
Two CD95 (APO‐1/Fas) signaling pathways
Scaffidi, C., Fulda, S., Srinivasan, A., Friesen, C., Li, F., Tomaselli, K. J., Debatin, K., Krammer, P. H., & Peter, M. E. (1998) · The EMBO Journal · doi:10.1093/emboj/17.6.1675 · Cited by 3,000
Activation and regulation of the inflammasomes
Latz, E., Xiao, T. S., & Stutz, A. (2013) · Nature Reviews Immunology · doi:10.1038/nri3452 · Cited by 2,884
AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC
Hornung, V., Ablasser, A., Charrel-Dennis, M., Bauernfeind, F., Horvath, G., Caffrey, D. R., Latz, E., & Fitzgerald, K. A. (2009) · Nature · doi:10.1038/nature07725 · Cited by 2,627
A novel heterodimeric cysteine protease is required for interleukin-1βprocessing in monocytes
Thornberry, N. A., Bull, H. G., Calaycay, J. R., Chapman, K. T., Howard, A. D., Kostura, M. J., Miller, D. K., Molineaux, S. M., Weidner, J. R., Aunins, J. G., et al. (1992) · Nature · doi:10.1038/356768a0 · Cited by 2,613
Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis
Shimada, K., Crother, T. R., Karlin, J., Dagvadorj, J., Chiba, N., Chen, S., Ramanujan, V. K., Wolf, A. J., Vergnes, L., Ojcius, D. M., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.01.009 · Cited by 2,282
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 738
Pathogen perception by NLRs in plants and animals: Parallel worlds
Duxbury, Z., Ma, Y., Furzer, O. J., Huh, S. U., Çevik, V., Jones, J. D. G., & Sarris, P. F. (2016) · BioEssays · doi:10.1002/bies.201600046 · Cited by 95
OxInflammatory Responses in the Wound Healing Process: A Systematic Review
Lopes, F. B., Sarandy, M. M., Novaes, R. D., Valacchi, G., & Gonçalves, R. V. (2024) · Antioxidants · doi:10.3390/antiox13070823 · Cited by 107
Wang, S., Xie, X., Lei, T., Zhang, K., Lai, B., Zhang, Z., Guan, Y., Mao, G., Xiao, L., & Wang, N. (2017) · Molecular Pharmacology · doi:10.1124/mol.116.108100 · Cited by 93
Role of Inflammasomes in Kidney Diseases via Both Canonical and Non-canonical Pathways
Xiang, H., Zhu, F., Xu, Z., & Xiong, J. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00106 · Cited by 96
The Inflammasome Adaptor ASC Induces Procaspase-8 Death Effector Domain Filaments
Vajjhala, P. R., Lu, A. Z., Brown, D. L., Pang, S. W., Sagulenko, V., Sester, D. P., Cridland, S. O., Hill, J. M., Schroder, K., Stow, J. L., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.687731 · Cited by 94
He, L., Peng, X., Zhu, J., Chen, X., Liu, H., Tang, C., Dong, Z., Liu, F., & Peng, Y. (2014) · American Journal of Nephrology · doi:10.1159/000369220 · Cited by 93
Inflammasomes of the intestinal epithelium
Sellin, M. E., Maslowski, K. M., Maloy, K. J., & Hardt, W. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.06.002 · Cited by 92
HMGB1 Increases IL-1β Production in Vascular Smooth Muscle Cells via NLRP3 Inflammasome
Kim, E. J., Park, S. Y., Baek, S. E., Jang, M. A., Lee, W. S., Bae, S. S., Kim, K., & Kim, C. D. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00313 · Cited by 91
Jin, X., Fu, W., Zhou, J., Shuai, N., Yang, Y., & Wang, B. (2021) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2021.5020 · Cited by 90
Tschöpe, C., Müller, I., Xia, Y., Savvatis, K., Pappritz, K., Pinkert, S., Lassner, D., Heimesaat, M. M., Spillmann, F., Miteva, K., et al. (2017) · Circulation: Heart Failure · doi:10.1161/circheartfailure.117.003870 · Cited by 88
Jia, X., Liu, B., Bao, L., Lv, Q., Li, F., Li, H., An, Y., Zhang, X., Cao, B., & Wang, C. (2018) · PLoS Pathogens · doi:10.1371/journal.ppat.1007428 · Cited by 87
Effects of Microglial Activation and Polarization on Brain Injury After Stroke
Dong, R., Huang, R., Wang, J., Liu, H., & Xu, Z. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.620948 · Cited by 87
Mohamed, I., Ishrat, T., Fagan, S. C., & El‐Remessy, A. B. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.6126 · Cited by 88
Advances in the molecular mechanisms of NLRP3 inflammasome activators and inactivators
Liu, D., Zeng, X., Li, X., Cui, C., Hou, R., Guo, Z., Mehta, J. L., & Wang, X. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.113863 · Cited by 88
Electrophilic Warhead-Based Design of Compounds Preventing NLRP3 Inflammasome-Dependent Pyroptosis
Cocco, M., Garella, D., Stilo, A. D., Borretto, E., Stevanato, L., Giorgis, M., Marini, E., Fantozzi, R., Miglio, G., & Bertinaria, M. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm501072b · Cited by 87
Inflammasome-Dependent Coagulation Activation in Sepsis
Wu, R., Wang, N., Comish, P. B., Tang, D., & Kang, R. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.641750 · Cited by 89
Microglial NLRP3 inflammasome activation in multiple sclerosis
(2020) · Advances in Protein Chemistry and Structural Biology · doi:10.1016/bs.apcsb.2019.08.007 · Cited by 83
Camilli, G., Bohm, M., Piffer, A. C., Lavenir, R., Williams, D. L., Neven, B., Grateau, G., Georgin‐Lavialle, S., & Quintin, J. (2020) · Journal of Clinical Investigation · doi:10.1172/jci134778 · Cited by 81
Liu, H., Zhang, X., Shi, P., Yuan, J., Jia, Q., Pi, C., Chen, T., Xiong, L., Chen, J., Tang, J., et al. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02768-z · Cited by 88
Design, Synthesis, and Evaluation of Acrylamide Derivatives as Direct NLRP3 Inflammasome Inhibitors
Cocco, M., Miglio, G., Giorgis, M., Garella, D., Marini, E., Costale, A., Regazzoni, L., Vistoli, G., Orioli, M., Massulaha‐Ahmed, R., et al. (2016) · ChemMedChem · doi:10.1002/cmdc.201600055 · Cited by 80
MicroRNAs as important regulators of the NLRP3 inflammasome
Zamani, P., Oskuee, R. K., Atkin, S. L., Navashenaq, J. G., & Sahebkar, A. (2019) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2019.05.004 · Cited by 80
Inflammasome inhibitors: promising therapeutic approaches against cancer
Xu, S., Li, X., Liu, Y., Xia, Y., Chang, R., & Zhang, C. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0755-0 · Cited by 80
The NLRP3 Inflammasome Mediates Inflammation Produced by Bladder Outlet Obstruction
Hughes, F. M., Hill, H. M., Wood, C. M., Edmondson, A. T., Dumas, A., Foo, W., Oelsen, J. M., Rac, G., & Purves, J. T. (2015) · The Journal of Urology · doi:10.1016/j.juro.2015.12.068 · Cited by 80
Unresolved issues in theories of autoimmune disease using myocarditis as a framework
Root-Bernstein, R. S., & Fairweather, D. (2014) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2014.11.022 · Cited by 77
Metaflammation: Tissue-Specific Alterations of the NLRP3 Inflammasome Platform in Metabolic Syndrome
Mastrocola, R., Aragno, M., Alloatti, G., Collino, M., Penna, C., & Pagliaro, P. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867324666170407123522 · Cited by 76
Moving towards a systems-based classification of innate immune-mediated diseases
Savic, S., Caseley, E. A., & McDermott, M. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-020-0377-5 · Cited by 80
ATP-Binding and Hydrolysis in Inflammasome Activation
Sandall, C. F., Ziehr, B. K., & MacDonald, J. A. (2020) · Molecules · doi:10.3390/molecules25194572 · Cited by 76
Salidroside Decreases Atherosclerosis Plaque Formation via Inhibiting Endothelial Cell Pyroptosis
Xing, S., Yang, J., Li, W., Li, J., Chen, L., Yang, Y.-T., Xia, L., Li, J., Wang, K., & Liu, X. (2020) · Inflammation · doi:10.1007/s10753-019-01106-x · Cited by 75
At the Crossing of ER Stress and MAMs: A Key Role of Sigma-1 Receptor?
Delprat, B., Crouzier, L., Su, T., & Maurice, T. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-12457-1_28 · Cited by 76
Li, J.-Y., Wang, Y.-Y., Shao, T., Fan, D., Lin, A., Xiang, L., & Shao, J.-Z. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.011751 · Cited by 76
Lawana, V., Singh, N., Sarkar, S., Charli, A., Jin, H., Anantharam, V., Kanthasamy, A. G., & Kanthasamy, A. (2017) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-017-9746-5 · Cited by 73
Differential role of the NLRP 3 inflammasome in infection and tumorigenesis
Tartey, S., & Kanneganti, T. (2019) · Immunology · doi:10.1111/imm.13046 · Cited by 74
Nunes, P. R., Viana-Mattioli, S., & Sandrim, V. C. (2021) · Cells · doi:10.3390/cells10112828 · Cited by 77
Luo, F., Li, H., Ma, W., Cao, J., Chen, Q., Lu, F., Qiu, M., Zhou, P., Xia, Z., Zeng, K., et al. (2023) · Cellular and Molecular Immunology · doi:10.1038/s41423-023-01112-y · Cited by 77
Schmidt, M., & Goebeler, M. (2015) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/ddg.12673 · Cited by 81
Monie, T. P., & Bryant, C. E. (2015) · Immunological Reviews · doi:10.1111/imr.12284 · Cited by 74
The NLRP3 Inflammasome Role in the Pathogenesis of Pregnancy Induced Hypertension and Preeclampsia
Socha, M. W., Malinowski, B., Puk, O., Dubiel, M., & Wiciński, M. (2020) · Cells · doi:10.3390/cells9071642 · Cited by 74
Tang, Z., Ji, L., Han, M., Xie, J., Zhong, F., Zhang, X., Su, Q., Yang, Z., Liu, Z., Gao, H., et al. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118065 · Cited by 72
Kouba, B. R., Camargo, A., Gil‐Mohapel, J., & Rodrigues, A. L. S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137077 · Cited by 77
Mitochondrial DNA signals driving immune responses: Why, How, Where?
Giordano, L., Ware, S. A., Lagranha, C. J., & Kaufman, B. A. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02042-0 · Cited by 82
Chun, J., Chung, H., Wang, X., Barry, R., Taheri, Z. M., Platnich, J. M., Ahmed, S. B., Trpkov, K., Hemmelgarn, B. R., Benediktsson, H., et al. (2016) · Scientific Reports · doi:10.1038/srep24667 · Cited by 71
Liu, H., Zhao, L., Yue, L., Wang, B., Li, X., Guo, H., Ma, Y., Yao, C., Gao, L., Deng, J., et al. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0108-8 · Cited by 72
NLRP3 is Required for Complement-Mediated Caspase-1 and IL-1beta Activation in ICH
Yao, S., Cao, F., Chen, J., Chen, W., Fan, R., Li, G., Zeng, Y.-C., Song, J., Xia, X., Han, C., et al. (2016) · Journal of Molecular Neuroscience · doi:10.1007/s12031-016-0874-9 · Cited by 73
n-3 Polyunsaturated Fatty Acids and Their Derivates Reduce Neuroinflammation during Aging
Joffre, C., Dinel, A., Chataigner, M., Pallet, V., & Layé, S. (2020) · Nutrients · doi:10.3390/nu12030647 · Cited by 80
Miteva, K., Pappritz, K., Sosnowski, M., El-Shafeey, M. E. A., Müller, I., Dong, F., Savvatis, K., Ringe, J., Tschöpe, C., & Linthout, S. V. (2018) · Scientific Reports · doi:10.1038/s41598-018-20686-6 · Cited by 72
α1-antitrypsin mitigates NLRP3-inflammasome activation in amyloid β1–42-stimulated murine astrocytes
Ebrahimi, T., Rust, M. I., Kaiser, S., Slowik, A., Beyer, C., Koczulla, A. R., Schulz, J. B., Habib, P., & Bach, J. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1319-x · Cited by 72
Kapétanovic, R., Bokil, N. J., & Sweet, M. J. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2015.02.005 · Cited by 70
Complement-mediated ‘bystander’ damage initiates host NLRP3 inflammasome activation
Suresh, R., Chandrasekaran, P., Sutterwala, F. S., & Mosser, D. M. (2016) · Journal of Cell Science · doi:10.1242/jcs.179291 · Cited by 68
Innate and adaptive immunity in atherosclerosis
Miteva, K., Madonna, R., Caterina, R. D., & Linthout, S. V. (2018) · Vascular Pharmacology · doi:10.1016/j.vph.2018.04.006 · Cited by 70
The Role of NF-κB Triggered Inflammation in Cerebral Ischemia
Jover‐Mengual, T., Hwang, J.-Y., Byun, H.-R., Court-Vazquez, B. L., Centeno, J. M., Burguete, M. C., & Zukin, R. S. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.633610 · Cited by 69
Evasion of inflammasome activation by microbial pathogens
Ulland, T. K., Ferguson, P. J., & Sutterwala, F. S. (2015) · Journal of Clinical Investigation · doi:10.1172/jci75254 · Cited by 71
Yu, S., Wang, D., Huang, L., Zhang, Y., Luo, R., Adah, D., Tang, Y., Zhao, K., & Lü, B. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.006508 · Cited by 69
NOD-Like Receptors: Guardians of Intestinal Mucosal Barriers
Claes, A.-K., Zhou, J. Y., & Philpott, D. J. (2015) · Physiology · doi:10.1152/physiol.00025.2014 · Cited by 75
Lee, P. P. W., Lobato‐Márquez, D., Pramanik, N., Sirianni, A., Daza-Cajigal, V., Rivers, E., Cavazza, A., Bouma, G., MOULDING, D. A., Hultenby, K. R., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01676-0 · Cited by 75
Inflammasome as a promising therapeutic target for cancer
Lee, C., Do, H. T. T., Her, J., Kim, Y., Seo, D., & Rhee, I. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116593 · Cited by 66
Molecular Mechanisms Underlying Neuroinflammation Elicited by Occupational Injuries and Toxicants
Pathak, D., & Sriram, K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032272 · Cited by 72
Bezbradica, J. S., Coll, R. C., & Schroder, K. (2016) · Cellular and Molecular Immunology · doi:10.1038/cmi.2016.11 · Cited by 67
Cardiovascular diseases, NLRP3 inflammasome, and western dietary patterns
Pavillard, L. E., Marín‐Aguilar, F., Bullón, P., & Cordero, M. D. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.03.018 · Cited by 67
NLRP 3 inflammasome: A likely target for the treatment of allergic diseases
Xiao, Y., Xu, W., & Su, W. (2018) · Clinical & Experimental Allergy · doi:10.1111/cea.13190 · Cited by 66
Liu, Q., Zhuang, Y., Song, X., Niu, Q., Sun, Q., Li, X., Li, N., Liu, B., Huang, F., & Qiu, Z. (2020) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-00535-x · Cited by 67
Sulfonylureas as Concomitant Insulin Secretagogues and NLRP3 Inflammasome Inhibitors
Hill, J. R., Coll, R. C., Sue, N., Reid, J. C., Dou, J., Holley, C. L., Pelingon, R., Dickinson, J. B., Biden, T. J., Schroder, K., et al. (2017) · ChemMedChem · doi:10.1002/cmdc.201700270 · Cited by 66
Coulon, P.-G. A., Dhanushkodi, N. R., Prakash, S., Srivastava, R., Roy, S., Alomari, N. I., Nguyen, A., Warsi, W. R., Ye, C., Carlos-Cruz, E. A., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01631 · Cited by 66
Xu, X., Huang, X., Zhang, L., Huang, X., Qin, Z., & Hua, F. (2021) · BMC Nephrology · doi:10.1186/s12882-021-02391-1 · Cited by 64
Zhang, Y., Zhang, H., Li, S., Huang, K., Jiang, L., & Wang, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.801337 · Cited by 65
Cao, Z., Fang, Y., Lu, Y., Qian, F., Ma, Q., He, M., Pi, H., Yu, Z., & Zhou, Z. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s106912 · Cited by 64
The role of keratinocytes in inflammation
Juráňová, J., Franková, J., & Ulrichová, J. (2017) · Journal of Applied Biomedicine · doi:10.1016/j.jab.2017.05.003 · Cited by 67
Inhibitory effects of phytochemicals on NLRP3 inflammasome activation: A review
Olcum, M., Tastan, B., Ercan, İ., Eltutan, B. I., & Genç, Ş. (2020) · Phytomedicine · doi:10.1016/j.phymed.2020.153238 · Cited by 63
Activation and regulation mechanisms of NOD-like receptors based on structural biology
Ohto, U. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.953530 · Cited by 63
The NLRP3 inflammasome: role in the pathobiology of chronic pain
Chen, C., & Smith, M. T. (2023) · Inflammopharmacology · doi:10.1007/s10787-023-01235-8 · Cited by 64
Role of Microgliosis and NLRP3 Inflammasome in Parkinson’s Disease Pathogenesis and Therapy
de Araújo, F. M., Cuenca‐Bermejo, L., Fernández‐Villalba, E., Costa, S. L., da Silva, V. D. A., & Herrero, M. T. (2021) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-020-01027-6 · Cited by 63
Plassmeyer, M. L., Alpan, O., Corley, M. J., Premeaux, T. A., Lillard, K., Coatney, P., Vaziri, T., Michalsky, S., Pang, A. P. S., Bukhari, Z., et al. (2021) · Allergy · doi:10.1111/all.14907 · Cited by 64
Self-adjuvanting cancer nanovaccines
Liao, Z., Huang, J., Lo, P., Lovell, J. F., Jin, H., & Yang, K. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01545-z · Cited by 66
Role of NF-κB during Mycobacterium tuberculosis Infection
Poladian, N., Orujyan, D., Narinyan, W., Oganyan, A. K., Navasardyan, I., Velpuri, P., Chorbajian, A., & Venketaraman, V. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021772 · Cited by 61
Somade, O. T., Ajayi, B. O., Safiriyu, O. A., Oyabunmi, O. S., & Akamo, A. J. (2019) · Toxicology Reports · doi:10.1016/j.toxrep.2019.07.010 · Cited by 64
Wang, N., Wu, S., Huang, L., Hu, Y., He, X., He, J., Hu, B., Xu, Y., Rong, Y., Yuan, C., et al. (2025) · Journal of Biomedical Science · doi:10.1186/s12929-025-01117-x · Cited by 62
Luteolin prevents THP-1 macrophage pyroptosis by suppressing ROS production via Nrf2 activation.
Zou, Y., Luo, X.-Z., Feng, Y., Fang, S., Tian, J., Yu, B., & Li, J. (2021) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2021.109573 · Cited by 56
NLRP3 promotes immune escape by regulating immune checkpoints: A pan-cancer analysis
Ding, Y., Yan, Y., Dong, Y., Xu, J., Su, W., Shi, W., Zou, Q., & Yang, X. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2021.108512 · Cited by 63
Alum: an old dog with new tricks
Wen, Y., & Shi, Y. (2016) · Emerging Microbes & Infections · doi:10.1038/emi.2016.40 · Cited by 60
Cui, Z., Liao, J., Cheong, N., Longoria, C., Cao, G., DeLisser, H. M., & Savani, R. C. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.08.002 · Cited by 63
The microbiome and cytosolic innate immune receptors
Liwinski, T., Zheng, D., & Elinav, E. (2020) · Immunological Reviews · doi:10.1111/imr.12901 · Cited by 61
Zhao, P., Cao, L., Wang, X., Dong, J., Zhang, N., Li, X., Li, J., Zhang, X., & Gong, P. (2021) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0009304 · Cited by 65
Yang, W., Liu, L., Wei, Y., Fang, C., Liu, S., Zhou, F., Li, Y., Zhao, G., Guo, Z., Luo, Y., et al. (2020) · Laboratory Investigation · doi:10.1038/s41374-020-00508-y · Cited by 58
Targeting NLRP3 Inflammasome in Translational Treatment of Nervous System Diseases: An Update
Yu, Q., Zhao, T., Liu, M., Cao, D., Li, J., Li, Y., Xia, M., Wang, X., Zheng, T., Liu, C., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.707696 · Cited by 61
Mechanisms of NLRP3 inflammasome activation and its role in NSAID-induced enteropathy
Higashimori, A., Watanabe, T., Nadatani, Y., Takeda, S., Otani, K., Tanigawa, T., Yamagami, H., Shiba, M., Tominaga, K., Fujiwara, Y., et al. (2015) · Mucosal Immunology · doi:10.1038/mi.2015.89 · Cited by 59
Interleukin-17A Induces IL-1β Secretion From RPE Cells Via the NLRP3 Inflammasome
Zhang, S., Yu, N., Zhang, R., Zhang, S., & Wu, J. (2016) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.15-17578 · Cited by 56
Hero turned villain: NLRP3 inflammasome-induced inflammation during influenza A virus infection
Ong, J. D. H., Mansell, A. S., & Tate, M. D. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.4mr0616-288r · Cited by 60
Innate Immune Receptors as Competitive Determinants of Cell Fate
Franz, K. M., & Kagan, J. C. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.05.009 · Cited by 60
Wang, M., Wang, Y., Xie, T., Zhan, P., Zou, J., Nie, X., Shao, J., Zhuang, M., Tan, C., Tan, J., et al. (2018) · Diabetologia · doi:10.1007/s00125-018-4755-3 · Cited by 59
P2X7 Receptor at the Crossroads of T Cell Fate
Rivas-Yáñez, E., Barrera‐Avalos, C., Parra-Tello, B., Briceño, P., Rosemblatt, M. V., Saavedra-Almarza, J., Rosemblatt, M. S., Acuña‐Castillo, C., Bono, M. R., & Sauma, D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21144937 · Cited by 62
Hyperactivity of Innate Immunity Triggers Pain via TLR2-IL-33-Mediated Neuroimmune Crosstalk
Huang, J., Gandini, M. A., Chen, L., M’Dahoma, S., Stemkowski, P. L., Chung, H., Muruve, D. A., & Zamponi, G. W. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108233 · Cited by 57
Proença, J. T., Barral, D. C., & Gordo, I. (2017) · Scientific Reports · doi:10.1038/s41598-017-04081-1 · Cited by 58
Medicinal plants and bioactive natural products as inhibitors of NLRP3 inflammasome
Bagherniya, M., Khedmatgozar, H., Fakheran, O., Xu, S., Johnston, T. P., & Sahebkar, A. (2021) · Phytotherapy Research · doi:10.1002/ptr.7118 · Cited by 60
Expression of urinary miRNAs targeting NLRs inflammasomes in bladder cancer
Mearini, E. E., Poli, G., Cochetti, G. G., Boni, A., Egidi, M. G., & Brancorsini, S. (2017) · OncoTargets and Therapy · doi:10.2147/ott.s132680 · Cited by 56
Guo, M., An, F., Yu, H., Wei, X., Hong, M., & Lü, Y. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.09.097 · Cited by 56
Zhi, X., Zhang, Y., Sun, S., Zhang, Z., Dong, H., Luo, X., Wei, Y., Lu, Z., Dou, Y., Wu, R., et al. (2019) · RNA Biology · doi:10.1080/15476286.2019.1700058 · Cited by 56
Soliman, N. A., Keshk, W. A., Rizk, F. H., & Ibrahim, M. A. (2018) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2018.11.002 · Cited by 54
Dexmedetomidine alleviates hepatic ischaemia‐reperfusion injury via the PI3K/AKT/Nrf2‐NLRP3 pathway
Wu, Y., Qiu, G., Zhang, H.-N., Zhu, L., Gao, C. H., Wang, Y., Li, Y., & Wu, W. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16871 · Cited by 54
Catorce, M. N., Acero, G., Pedraza‐Chaverrí, J., Fragoso, G., Govezensky, T., & Gevorkian, G. (2016) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2016.05.008 · Cited by 54
A Role for the Inflammasome in Spontaneous Labor at Term with Acute Histologic Chorioamnionitis
Gomez‐Lopez, N., Romero, R. J., Xu, Y., Plazyo, O., Unkel, R., Than, N. G., Chaemsaithong, P., Chaiworapongsa, T., Dong, Z., Tarca, A. L., et al. (2016) · Reproductive Sciences · doi:10.1177/1933719116675058 · Cited by 56
Pellegrini, C., Fornai, M., Colucci, R., Benvenuti, L., D’Antongiovanni, V., Natale, G., Fulceri, F., Giorgis, M., Marini, E., Gastaldi, S., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01405 · Cited by 53
Metadata
- Authors
- Sutterwala, F. S., Haasken, S., & Cassel, S. L.
- Affiliations
- University of Iowa (US)
- Corresponding author
- Sutterwala, Fayyaz S.
- Venue
- Annals of the New York Academy of Sciences
- Publisher
- Wiley
- Published
- 2014-05-19
- Volume
- 1319
- Issue
- 1
- Pages
- 82-95
- ISSN
- 0077-8923 (ISSN-L)
- 1749-6632
- PMC
- PMC4074217
- OpenAlex
- W1636793459
- Cited by
- 736
- References
- 82
- Citations by year
- 2026: 25 · 2025: 54 · 2024: 58 · 2023: 68 · 2022: 85 · 2021: 88 · 2020: 81 · 2019: 52 · 2018: 60 · 2017: 57 · 2016: 57 · 2015: 42 · 2014: 8
- FWCI
- 5.18
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Annals of the New York Academy of Sciences (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (AI087630, AI104706, AI007511)
- Asthma and Allergy foundation of America
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › IL-33, ST2, and ILC Pathways
- Keywords
- NLRP3 inflammasome, inflammasome activation, inflammasome priming, caspase-1, pyroptosis, innate immunity, damage-associated molecular patterns, pathogen-associated molecular patterns
- MeSH terms
- NLR Family, Pyrin Domain-Containing 3 Protein, Animals, Carrier Proteins, Cell Survival, Humans, Cell Death, Adaptive Immunity, Inflammasomes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review